MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $534,000 | -6.3% | 4,800 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $570,000 | +57.0% | 4,800 | +49.8% | 0.00% | 0.0% |
Q2 2020 | $363,000 | -42.2% | 3,205 | -46.5% | 0.00% | 0.0% |
Q2 2019 | $628,000 | -14.9% | 5,988 | +1.7% | 0.00% | 0.0% |
Q1 2019 | $738,000 | +1.0% | 5,888 | -9.2% | 0.00% | 0.0% |
Q4 2018 | $731,000 | -74.5% | 6,488 | -51.6% | 0.00% | -75.0% |
Q3 2018 | $2,868,000 | -39.0% | 13,392 | -20.3% | 0.00% | -42.9% |
Q2 2018 | $4,699,000 | +390.5% | 16,800 | +104.9% | 0.01% | +600.0% |
Q1 2018 | $958,000 | – | 8,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |